Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus remifentanil dose-finding for pediatric bronchoscopy anesthesia
ChiCTR2500101665Phase 4Completed
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Apr 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol, remifentanil and lidocaine in pneumonia (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: ED50 and ED95 of ciprofol combined with remifentanil in children aged 3-7 years and ED50 and ED95 of ciprofol combined with remifentanil in children aged 8-12 years. Started Apr 2025; status: completed.
02
Drugs
ciprofolremifentanillidocaine
03
Conditions
pneumonia
Beyond the preview
Go deeper on ChiCTR2500101665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101665.